Gastrointestinal agent
DG01975 Agents for peptic ulcer
Remark
ATC code:
A02BX06
Efficacy
Anti-ulcerative, Gastrin (cholecystokinin B) receptor antagonist
Target
CCKBR [HSA:887] [KO:K04195]
Pathway
hsa04971
Gastric acid secretion
Interaction
Structure map
map07038
Antiulcer drugs
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02BX06 Proglumide
D01818 Proglumide (JP18/USAN/INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01975 Agents for peptic ulcer
D01818 Proglumide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Cholecystokinin
CCKBR
D01818 Proglumide (JP18/USAN/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01818 Proglumide
Other DBs
CAS:
6620-60-6
PubChem:
7848880
ChEBI:
32058
LigandBox:
D01818
NIKKAJI:
J237.406D
KCF data
ATOM 24
1 C1a C 19.9298 -15.6483
2 C1b C 21.1407 -16.3424
3 C1b C 22.3516 -15.6414
4 N1c N 23.5625 -16.3353
5 C5a C 24.7733 -15.6342
6 C1c C 25.9842 -16.3281
7 C1b C 27.1951 -15.6271
8 C1b C 28.4060 -16.3212
9 C6a C 29.6169 -15.6201
10 O6a O 30.8277 -16.3140
11 C1b C 23.5655 -17.7373
12 C1b C 22.3528 -18.4411
13 C1a C 22.3560 -19.8432
14 O5a O 24.7703 -14.2322
15 N1b N 25.9873 -17.7302
16 C5a C 27.2031 -18.4287
17 C8y C 27.2061 -19.8308
18 O5a O 28.4157 -17.7249
19 O6a O 29.6138 -14.2181
20 C8x C 25.9954 -20.5282
21 C8x C 25.9985 -21.9303
22 C8x C 27.2143 -22.6286
23 C8x C 28.4271 -21.9249
24 C8x C 28.4240 -20.5228
BOND 24
1 1 2 1
2 12 13 1
3 6 7 1
4 5 14 2
5 3 4 1
6 6 15 1
7 7 8 1
8 15 16 1
9 16 17 1
10 8 9 1
11 16 18 2
12 4 5 1
13 9 19 2
14 9 10 1
15 2 3 1
16 4 11 1
17 5 6 1
18 11 12 1
19 17 20 2
20 20 21 1
21 21 22 2
22 22 23 1
23 23 24 2
24 24 17 1